Radiotherapy sensitivity in breast cancer is influenced by the DNA cytosine deaminase APOBEC3B

被引：0
|
作者：
Span, P. N. [1 ]
Post, A. [1 ]
Martens, J. W. M. [2 ,3 ]
Harris, R. S. [4 ]
机构：
[1] Radboud Univ Nijmegen, Dept Radiat Oncol, Med Ctr, Nijmegen, Netherlands
[2] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands
[3] Canc Genom Netherlands, Rotterdam, Netherlands
[4] Univ Minnesota, Masonic Canc Ctr, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)31692-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0443
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [21] DNA replication stress: a source of APOBEC3B expression in breast cancer
    Cescon, David W.
    Haibe-Kains, Benjamin
    GENOME BIOLOGY, 2016, 17
  • [22] APOBEC3B drives mutagenesis in breast cancer
    Harris, R. S.
    CANCER RESEARCH, 2013, 73
  • [23] DNA replication stress: a source of APOBEC3B expression in breast cancer
    David W. Cescon
    Benjamin Haibe-Kains
    Genome Biology, 17
  • [24] ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells
    Yasuhiro Kazuma
    Kotaro Shirakawa
    Yusuke Tashiro
    Hiroyuki Yamazaki
    Ryosuke Nomura
    Yoshihito Horisawa
    Suguru Takeuchi
    Emani Stanford
    Yoshinobu Konishi
    Hiroyuki Matsui
    Tadahiko Matsumoto
    Fumiko Tanabe
    Ryo Morishita
    Shinji Ito
    Akifumi Takaori-Kondo
    Scientific Reports, 12
  • [25] ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells
    Kazuma, Yasuhiro
    Shirakawa, Kotaro
    Tashiro, Yusuke
    Yamazaki, Hiroyuki
    Nomura, Ryosuke
    Horisawa, Yoshihito
    Takeuchi, Suguru
    Stanford, Emani
    Konishi, Yoshinobu
    Matsui, Hiroyuki
    Matsumoto, Tadahiko
    Tanabe, Fumiko
    Morishita, Ryo
    Ito, Shinji
    Takaori-Kondo, Akifumi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [26] APOBEC3B is an enzymatic source of mutation in breast cancer
    Michael B. Burns
    Lela Lackey
    Michael A. Carpenter
    Anurag Rathore
    Allison M. Land
    Brandon Leonard
    Eric W. Refsland
    Delshanee Kotandeniya
    Natalia Tretyakova
    Jason B. Nikas
    Douglas Yee
    Nuri A. Temiz
    Duncan E. Donohue
    Rebecca M. McDougle
    William L. Brown
    Emily K. Law
    Reuben S. Harris
    Nature, 2013, 494 : 366 - 370
  • [27] APOBEC3B is an enzymatic source of mutation in breast cancer
    Burns, Michael B.
    Lackey, Lela
    Carpenter, Michael A.
    Rathore, Anurag
    Land, Allison M.
    Leonard, Brandon
    Refsland, Eric W.
    Kotandeniya, Delshanee
    Tretyakova, Natalia
    Nikas, Jason B.
    Yee, Douglas
    Temiz, Nuri I. A.
    Donohue, Duncan E.
    McDougle, Rebecca M.
    Brown, William L.
    Law, Emily K.
    Harris, Reuben S.
    NATURE, 2013, 494 (7437) : 366 - 370
  • [28] The deaminase APOBEC3B triggers the death of cells lacking uracil DNA glycosylase
    Serebrenik, Artur A.
    Starrett, Gabriel J.
    Leenen, Sterre
    Jarvis, Matthew C.
    Shaban, Nadine M.
    Salamango, Daniel J.
    Nilsen, Hilde
    Brown, William L.
    Harris, Reuben S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (44) : 22158 - 22163
  • [29] The APOBEC3B cytidine deaminase is an adenovirus restriction factor
    Lejeune, Noemie
    Mathieu, Sarah A.
    Decloux, Alexandra F.
    Poulain, Florian
    Blockx, Zoe F.
    Raymond, Kyle
    Willemart, Kevin F.
    Vartanian, Jean-Pierre
    Suspene, Rodolphe F.
    Gillet, Nicolas
    PLOS PATHOGENS, 2023, 19 (02)
  • [30] DNA deaminase APOBEC3B regulates theresponse to PARP inhibitors of epithelial ovarian cancer stem cells
    Isquith, Jane
    Pham, Jessica
    Phavong, Robert
    Rivera, Maria
    Fisch, Kathleen
    Jamieson, Catriona
    McHale, Michael
    Eskander, Ramez
    Jiang, Qingfei
    CANCER RESEARCH, 2022, 82 (12)
12345